FSSAI

Nira Life Sciences Pvt. Ltd. is recognized as one of India's First and  leading manufacturers of Lysine Clonixinate API. 

The company has established itself as a trusted supplier of this non-steroidal anti-inflammatory drug (NSAID), which is used for treating pain and inflammation. 

Our state-of-the-art production facilities and compliance with WHO-cGMP guidelines have positioned them as a prominent player in the pharmaceutical industry.

Introducing the company brochure of Nira Life Sciences Pvt. Ltd., proudly based in India. 

This brochure provides an in-depth overview of our company profile, highlighting our mission, values, and commitment to advancing life sciences. 


Additionally, it details our diverse product portfolio, showcasing the innovative solutions we offer to meet the evolving needs of the healthcare industry. 


We invite you to explore our offerings and learn more about how we are making a difference in the field of life sciences. 

NIRA LIFE SCIENCES PRIVATE LIMITED is a leading entity in the Indian pharmaceutical manufacturing sector, currently preparing for the launch of our upcoming production facility. 

This initiative is designed to adhere to US FDA and various regulatory standards, reflecting our commitment to establishing a formidable presence on the global stage.
Nira Life is poised to become the world's largest producer of its key active pharmaceutical ingredient, Mefenamic Acid, by 2025. 

We are excited to contribute our capabilities to the global healthcare market and to serve effectively in this essential sector along with product range of,


BENFOTIAMINE / NITAZOXANIDE / TOLFENAMIC ACID & CLONIXIN LYSINATE or LYSINE CLONIXINATE

A WHO GMP and Product Permission

Halal Certificate

GLP Certificate